
S11 Ep45: Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD
OncLive® On Air
00:00
Long-term Outcomes and AOEs in OPTIC
Bradley Hunter reviews five-year OPTIC data showing similar survival and lower arterial occlusive event rates at lower doses.
Play episode from 07:29
Transcript


